Literature DB >> 19703248

Evolution of HIV-1 in a patient population failing multiple-drug therapy.

Shaolin Hong1, Jingjiang Cao, Ya-ting Tu.   

Abstract

To understand the evolutionary pathway of the multi-drug-resistant virus HIV-1 under drug-induced selection pressure, plasma from seven patients from baseline to different intervals post-treatment failure were used in RT-PCR protocols. Multiple clones were sequenced for each time point. Drug-resistant mutations were detected in five patients. Phylogenetic analysis showed that at different time points, viral sequences clustered separately and formed independent lineages. Genetic diversity decreased from 1.59 to 0.55, whereas non-synonymous/synonymous mutation ratios increased from 0.067 to 0.118, respectively. These data suggest that the virus population changed dynamically and clustered in a time point-specific manner whereas genetic diversity decreased consistently.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703248     DOI: 10.1111/j.1348-0421.2009.00153.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.

Authors:  Maria L Ekstrand; Anita Shet; Sara Chandy; Girija Singh; Ranjani Shamsundar; Vidya Madhavan; Shanmugam Saravanan; Elsa Heylen; Nagalingeswaran Kumarasamy
Journal:  Int Health       Date:  2011-03       Impact factor: 2.473

2.  RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I.

Authors:  Mayra Solis; Peyman Nakhaei; Mohammad Jalalirad; Judith Lacoste; Renée Douville; Meztli Arguello; Tiejun Zhao; Michael Laughrea; Mark A Wainberg; John Hiscott
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

3.  Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children.

Authors:  Maria M James; Lei Wang; Deborah Donnell; Matthew M Cousins; Linda Barlow-Mosha; Jessica M Fogel; William I Towler; Allison L Agwu; Danstan Bagenda; Micheal Mubiru; Philippa Musoke; Susan H Eshleman
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

4.  HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).

Authors:  Stéphanie Olière; Eduardo Hernandez; Agnès Lézin; Meztli Arguello; Renée Douville; Thi Lien-Anh Nguyen; Stéphane Olindo; Gérard Panelatti; Mirdad Kazanji; Peter Wilkinson; Rafick-Pierre Sékaly; Raymond Césaire; John Hiscott
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

5.  Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061).

Authors:  Iris Chen; Gordon Chau; Jing Wang; William Clarke; Mark A Marzinke; Vanessa Cummings; Autumn Breaud; Oliver Laeyendecker; Sheldon D Fields; Sam Griffith; Hyman M Scott; Steven Shoptaw; Carlos Del Rio; Manya Magnus; Sharon Mannheimer; Hong-Van Tieu; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.